Siirry päänavigointiin
Siirry hakuun
Siirry pääsisältöön
Tampereen yliopiston tutkimusportaali Etusivu
Tuki ja usein esitetyt kysymykset
English
Suomi
Etusivu
Profiilit
Tutkimusyksiköt
Tutkimustuotos
Aktiviteetit
Tietoaineistot
Tutkimusinfrastruktuurit
Lehtileikkeet
Palkinnot
Haku asiantuntemuksen, nimen tai kytköksen perusteella
Characterization of Novel Long Noncoding RNAs in Prostate Cancer
Annika Kohvakka
Biolääketiede
Tutkimustuotos
:
Väitöskirja
›
Collection of Articles
Yleiskatsaus
Sormenjälki
Sormenjälki
Sukella tutkimusaiheisiin 'Characterization of Novel Long Noncoding RNAs in Prostate Cancer'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.
Järjestys:
Painoarvo
Aakkosjärjestyksessä
Keyphrases
Prostate Cancer
100%
Long Non-coding RNA (LncRNA)
100%
Tampere
50%
In Cancer
37%
Prostate Cancer Cells
25%
Aberrant Expression
25%
Molecular Mechanism
12%
Finland
12%
Publicly Available
12%
Cell-based
12%
Genetic Modification
12%
Europe
12%
Expression Profile
12%
Clinical Patients
12%
Molecular Methods
12%
Expression Level
12%
Leading Causes of Death
12%
Therapeutic Target
12%
Putative Drug Targets
12%
Prostate Cancer Progression
12%
Androgens
12%
Cancer Mortality
12%
AKT1
12%
Cancer-related
12%
Novel Diagnostics
12%
Health Systems
12%
Functional Role
12%
Diagnostic Methods
12%
Androgen Receptor
12%
Next-generation Sequencing
12%
Diagnostic Biomarker
12%
Cancer Cases
12%
Role in Cancer
12%
Cancer Development
12%
Molecular Potential
12%
Cancer Causes
12%
Prostate Radiotherapy
12%
Prostate Cancer Model
12%
Cancer Progression
12%
High-level Expression
12%
Molecular Pathways
12%
Dysregulation
12%
Prostate-specific Antigen
12%
Cancer-specific
12%
Prognostic Biomarker
12%
Biomarker Potential
12%
Regulatory Potential
12%
Patients with Prostate Cancer
12%
TMPRSS2-ERG Fusion
12%
Lethal Cancer
12%
Cancer Cell Migration
12%
Cancer Cell Proliferation
12%
Cellular Context
12%
Financial Burden
12%
Specific Transcription Factor
12%
Current Diagnostics
12%
Emotional Burden
12%
Protein Translation
12%
Functional Potential
12%
Biomarker Candidates
12%
Physical Burden
12%
MTORC1 Pathway
12%
Biotechnological Processes
12%
Patient Materials
12%
Prospective Biomarkers
12%
Biochemistry, Genetics and Molecular Biology
Long Noncoding RNA
100%
Cancer Cell
28%
Cell Proliferation
14%
RNA
14%
Transcription Factors
14%
Cancer Mortality
14%
Next Generation Sequencing
14%
Cell Migration
14%
Androgen Receptor
14%
Gene Mutation
14%
Prostate-Specific Antigen
14%
TMPRSS2
14%
Translation (Protein Synthesis)
14%
Immunology and Microbiology
Prostate
100%
Cancer Cell
15%
Cell Proliferation
7%
Cell Migration
7%
Next Generation Sequencing
7%
Cancer Mortality
7%
Gene Mutation
7%
Prostate Specific Antigen
7%
Prognostic Biomarker
7%
Transcription Factors
7%